Form 13-F position report

HTG MOLECULAR DIAGNOSTICS I

Reported by HighMark Wealth Management LLC

HTGM CUSIP 40434H203 Manager CIK 0001802451

Reported 0 shares, down 6,966 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 40000
2021-12-31 38000
2022-03-31 10000
2022-06-30 7000
2022-09-30 4000
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for HTG MOLECULAR DIAGNOSTICS I held by HighMark Wealth Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -6,966 (-100.0%) 0 $0 2023-02-02
Q3 2022 Unchanged 6,966 0 (0.0%) < 0.01% $4,000 2022-10-21
Q2 2022 Unchanged 6,966 0 (0.0%) < 0.01% $7,000 2022-07-19
Q1 2022 Unchanged 6,966 0 (0.0%) < 0.01% $10,000 2022-04-25
Q4 2021 Unchanged 6,966 0 (0.0%) 0.02% $38,000 2022-01-20
Q3 2021 Unchanged 6,966 0 (0.0%) 0.03% $40,000 2021-11-01
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

19 managers reported HTG MOLECULAR DIAGNOSTICS I for Q4 2022.

Managers reporting HTG MOLECULAR DIAGNOSTICS I in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RENAISSANCE TECHNOLOGIES LLC Reduced 0 -86,402 0 $0 9 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 0 -47,178 0 $0 9 qtrs
VANGUARD GROUP INC Reduced 0 -70,922 0 $0 9 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 0 -23,683 0 $0 6 qtrs
STATE STREET CORPORATION Reduced 0 -14,455 0 $0 7 qtrs
Allworth Financial LP Reduced 0 -3,327 0 $0 9 qtrs
Tower Research Capital LLC TRC Reduced 0 -4,508 0 $0 9 qtrs
Virtu Financial LLC Reduced 0 -72,452 0 $0 3 qtrs
ROYAL BANK OF CANADA Reduced 0 -95 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 02, 2023
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.